BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 22978174)

  • 1. [Function of tumor suppressor p53 and its role in antiviral immunity].
    Yan WJ; Wu KB; Ma ZY
    Bing Du Xue Bao; 2012 Jun; 28(4):462-70. PubMed ID: 22978174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dual Role of p53 in Innate Antiviral Immunity.
    Rivas C; Aaronson SA; Munoz-Fontela C
    Viruses; 2010 Jan; 2(1):298-313. PubMed ID: 21994612
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integration of interferon-alpha/beta signalling to p53 responses in tumour suppression and antiviral defence.
    Takaoka A; Hayakawa S; Yanai H; Stoiber D; Negishi H; Kikuchi H; Sasaki S; Imai K; Shibue T; Honda K; Taniguchi T
    Nature; 2003 Jul; 424(6948):516-23. PubMed ID: 12872134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of IFN regulatory factor 5 transcription factor in antiviral immunity and tumor suppression.
    Yanai H; Chen HM; Inuzuka T; Kondo S; Mak TW; Takaoka A; Honda K; Taniguchi T
    Proc Natl Acad Sci U S A; 2007 Feb; 104(9):3402-7. PubMed ID: 17360658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome guardian p53 and viral infections.
    Sato Y; Tsurumi T
    Rev Med Virol; 2013 Jul; 23(4):213-20. PubMed ID: 23255396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential contribution of tumor suppressor p53 in the host defense against hepatitis C virus.
    Dharel N; Kato N; Muroyama R; Taniguchi H; Otsuka M; Wang Y; Jazag A; Shao RX; Chang JH; Adler MK; Kawabe T; Omata M
    Hepatology; 2008 Apr; 47(4):1136-49. PubMed ID: 18220274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The pathological response to DNA damage does not contribute to p53-mediated tumour suppression.
    Christophorou MA; Ringshausen I; Finch AJ; Swigart LB; Evan GI
    Nature; 2006 Sep; 443(7108):214-7. PubMed ID: 16957739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of DNA damage responses in p53 biology.
    Speidel D
    Arch Toxicol; 2015 Apr; 89(4):501-17. PubMed ID: 25618545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p53 efficiently suppresses tumor development in the complete absence of its cell-cycle inhibitory and proapoptotic effectors p21, Puma, and Noxa.
    Valente LJ; Gray DH; Michalak EM; Pinon-Hofbauer J; Egle A; Scott CL; Janic A; Strasser A
    Cell Rep; 2013 May; 3(5):1339-45. PubMed ID: 23665218
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging roles of p53 and other tumour-suppressor genes in immune regulation.
    Muñoz-Fontela C; Mandinova A; Aaronson SA; Lee SW
    Nat Rev Immunol; 2016 Dec; 16(12):741-750. PubMed ID: 27667712
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.
    Burns TF; Bernhard EJ; El-Deiry WS
    Oncogene; 2001 Aug; 20(34):4601-12. PubMed ID: 11498783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53 and metabolism: Inside the TIGAR.
    Green DR; Chipuk JE
    Cell; 2006 Jul; 126(1):30-2. PubMed ID: 16839873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host defense, viruses and apoptosis.
    Barber GN
    Cell Death Differ; 2001 Feb; 8(2):113-26. PubMed ID: 11313713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deletion of Irf5 protects hematopoietic stem cells from DNA damage-induced apoptosis and suppresses γ-irradiation-induced thymic lymphomagenesis.
    Bi X; Feng D; Korczeniewska J; Alper N; Hu G; Barnes BJ
    Oncogene; 2014 Jun; 33(25):3288-97. PubMed ID: 23912454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ASPP [corrected] and cancer.
    Trigiante G; Lu X
    Nat Rev Cancer; 2006 Mar; 6(3):217-26. PubMed ID: 16498444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53.
    Albrechtsen N; Dornreiter I; Grosse F; Kim E; Wiesmüller L; Deppert W
    Oncogene; 1999 Dec; 18(53):7706-17. PubMed ID: 10618711
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gamma interferon-inducible protein 10 induces HeLa cell apoptosis through a p53-dependent pathway initiated by suppression of human papillomavirus type 18 E6 and E7 expression.
    Zhang HM; Yuan J; Cheung P; Chau D; Wong BW; McManus BM; Yang D
    Mol Cell Biol; 2005 Jul; 25(14):6247-58. PubMed ID: 15988033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A dance between interferon-alpha/beta and p53 demonstrates collaborations in tumor suppression and antiviral activities.
    Pestka S
    Cancer Cell; 2003 Aug; 4(2):85-7. PubMed ID: 12957282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cell death machinery governed by the p53 tumor suppressor in response to DNA damage.
    Yoshida K; Miki Y
    Cancer Sci; 2010 Apr; 101(4):831-5. PubMed ID: 20132225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference with p53 functions in human viral infections, a target for novel antiviral strategies?
    Lazo PA; Santos CR
    Rev Med Virol; 2011 Sep; 21(5):285-300. PubMed ID: 21726011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.